Welcome to LookChem.com Sign In|Join Free
  • or
7-bromo-2-methylimidazo[1,2-a]pyridine is a heterocyclic aromatic chemical compound with the molecular formula C8H7BrN2. It contains a bromine atom and a methyl group, and is known for its mutagenic properties and classification as a Group 2B carcinogen by the International Agency for Research on Cancer.

1194375-40-0

Post Buying Request

1194375-40-0 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1194375-40-0 Usage

Uses

Used in Research and Development:
7-bromo-2-methylimidazo[1,2-a]pyridine is utilized as a research compound for studying its mutagenic and carcinogenic effects. This helps scientists understand the mechanisms of its action and develop methods to reduce its presence in food products.
Used in Food Industry:
Efforts are being made to reduce the levels of 7-bromo-2-methylimidazo[1,2-a]pyridine in food, particularly in grilled and smoked meats cooked at high temperatures. This is done to minimize the risk of cancer associated with its consumption.
Used in Public Health and Safety:
7-bromo-2-methylimidazo[1,2-a]pyridine is a focus in public health and safety initiatives aimed at developing safer cooking methods and reducing human exposure to this chemical compound.

Check Digit Verification of cas no

The CAS Registry Mumber 1194375-40-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,9,4,3,7 and 5 respectively; the second part has 2 digits, 4 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1194375-40:
(9*1)+(8*1)+(7*9)+(6*4)+(5*3)+(4*7)+(3*5)+(2*4)+(1*0)=170
170 % 10 = 0
So 1194375-40-0 is a valid CAS Registry Number.

1194375-40-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 7-bromo-2-methylimidazo[1,2-a]pyridine

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1194375-40-0 SDS

1194375-40-0Relevant academic research and scientific papers

Heterocyclic kinase inhibitor

-

Paragraph 0418-0421, (2021/03/31)

The invention belongs to the technical field of medicines, and particularly relates to a heterocyclic DNA-PK kinase inhibitor compound shown as a general formula (I), a pharmaceutically acceptable salt and an isomer thereof, a pharmaceutical composition and preparation containing the compound, the pharmaceutically acceptable salt and the isomer thereof, a method for preparing the compound, the pharmaceutically acceptable salt and the isomer thereof, and application of the compound, the pharmaceutically acceptable salt and the isomer thereof.

SUBSTITUTED HETEROARYL COMPOUNDS AND METHODS OF USE

-

Paragraph 000380, (2019/06/05)

The present invention provides novel heteroaryl compounds, pharmaceutical acceptable salts and formulations thereof. They are useful in preventing, managing, treating or lessening the severity of a protein kinase-mediated disease. The invention also provides pharmaceutically acceptable compositions comprising such compounds and methods of using the compositions in the treatment of protein kinase-mediated disease.

Substituted heteroaryl compounds and compositions and uses thereof (by machine translation)

-

Paragraph 0652; 0658; 0659; 0660, (2019/06/07)

The invention discloses substituted heteroaryl compounds and compositions thereof and their use. The compounds of formula (I) compound or type shown in (I) a compound represented by stereo isomers, tautomers, nitrogen oxide, solvate, metabolite, pharmaceutically acceptable salt or its prodrug. The invention also provides a pharmaceutical composition, the compounds and pharmaceutical compositions can be regulated protein kinase, particularly Aurora kinase and JAK kinase activity, for the prevention, treatment, treatment and reduce protein kinase, in particular JAK kinase activity mediated diseases or disorders. (by machine translation)

DIBENZOOXEPIN DERIVATIVE

-

Paragraph 0399, (2014/06/24)

A dibenzoxepin derivative represented by the following general formula (I) wherein Y is a hydrogen atom and the like, RA is a hydrogen atom and the like, X is the formula (b3) wherein RB is a hydrogen atom and the like, and the like,

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1194375-40-0